LIGATION OF HLA CLASS-II MOLECULES PROMOTES SENSITIVITY TO CD95 (FAS ANTIGEN, APO-1)-MEDIATED APOPTOSIS

被引:36
作者
YOSHINO, T
CAO, L
NISHIUCHI, R
MATSUO, Y
YAMADORI, I
KONDO, E
TERAMOTO, N
HAYASHI, K
TAKAHASHI, K
KAMIKAWAJI, N
AKAGI, T
机构
[1] HAYASHIBARA BIOCHEM LABS INC,FUJISAKI CELL CTR,OKAYAMA,JAPAN
[2] KYUSHU UNIV,MED INST BIOREGULAT,FUKUOKA 812,JAPAN
关键词
HLA CLASS II; FAS ANTIGEN; APO-1; CD95; APOPTOSIS;
D O I
10.1002/eji.1830250811
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD95 (Fas antigen/APO-1) is up-regulated in activated lymphocytes, and monoclonal antibody (mAb) to CD95 induces apoptosis. HLA class II molecules play a key role in antigen presentation, ligation of which induces signal transduction. We examined 18 lymphoid cell lines (15 B cell and 3 T cell lines) to investigate the effects of ligation of HLA class II molecules on CD95-mediated apoptosis. All of the five immature B cell lines were sensitive to anti-CD95 mAb, and ligation of HLA class II molecules promoted CD95-mediated apoptosis. In seven B-blastoid cell lines, two Burkitt lines were resistant to anti-CD95 mAb in spite of high expression of CD95. In three of five non-Burkitt B-blastoid lines, CD95-mediated apoptosis was augmented by treatment with anti-HLA class II mAb, while the other two lines lacking CD95 were resistant to anti-CD95 mAb. Three plasmacytic cell lines showed CD95-mediated apoptosis, but enhancement by anti-HLA class II mAb was slight in one cell line and was not observed in the other two lines. Out of three HLA class II antigen-positive T cell lines, CD95-mediated apoptosis was observed to some degree in one cell line but was not promoted by the treatment with anti-KLA class II mAb, and the other two cell lines were resistant to anti-CD95 mAb. Ligation of HLA class II molecules did not alter CD95 expression in the five cell lines examined, except Su-DHL-4 originated from a follicular lymphoma, which showed slight up-regulation. Taken together, ligation of HLA class II molecules apparently promotes CD95-mediated apoptosis in immature B cells and non-Burkitt a blasts. These findings highlight the role of HLA class LI molecules in CD95-mediated apoptosis, which may facilitate rapid clearance of functionally useless cells from the: immune system and might be involved in negative selection of B cells.
引用
收藏
页码:2190 / 2194
页数:5
相关论文
共 50 条
[31]   Expression and detection of functional activity of Fas/APO-1/CD95 antigen, mediating apoptosis in human hemoblastoses. [J].
Baryshnikov, AY ;
Shelepov, VP ;
Kuznetsov, SV ;
Shishkin, YV ;
Sedyakhina, NP ;
Donskaya, ON ;
Zabotina, TN ;
Polosukhina, ER ;
Turkina, AG ;
Khoroshko, ND .
GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1996, 41 (05) :42-44
[32]   Isolation and characterization of ICO-160 monoclonal antibodies to CD95(FAS/APO-1) antigen that mediates apoptosis [J].
Polosukhina, ER ;
Zabotina, TN ;
Shishkin, YV ;
Kadagidze, ZG ;
Baryshnikov, AY .
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1998, 125 (06) :594-596
[33]   Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma [J].
Gross, N ;
Balmas, K ;
Brognara, CB ;
Tschopp, J .
MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (01) :111-114
[34]   THE APO-1/FAS (CD95) RECEPTOR IS EXPRESSED IN HOMOZYGOUS MRL/LPR MICE [J].
MARIANI, SM ;
MATIBA, B ;
ARMANDOLA, EA ;
KRAMMER, PH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) :3119-3123
[35]   Soluble CD95 (Fas/APO-1) in Malignant Glioma: (No) Implications for CD95-based Immunotherapy? [J].
Johannes R. Streffer ;
Monika Schuster ;
Frauke Zipp ;
Michael Weller .
Journal of Neuro-Oncology, 1998, 40 :233-235
[36]   CD95/Fas/Apo-1-mediated signal transduction [J].
Schlottmann, K ;
Coggeshall, KM .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 1996, 6 (06) :345-360
[37]   Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils [J].
Luttmann, W ;
Opfer, A ;
Dauer, E ;
Foerster, M ;
Matthys, H ;
Eibel, H ;
Schulze-Osthoff, K ;
Kroegel, C ;
Virchow, JC .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (07) :2057-2065
[38]   Soluble CD95 (Fas/APO-1) in malignant glioma: (No) implications for CD95-based immunotherapy? [J].
Streffer, JR ;
Schuster, M ;
Zipp, F ;
Weller, M .
JOURNAL OF NEURO-ONCOLOGY, 1998, 40 (03) :233-235
[39]   Control of neuronal branching by the death receptor CD95 (Fas/Apo-1) [J].
C Zuliani ;
S Kleber ;
S Klussmann ;
T Wenger ;
M Kenzelmann ;
N Schreglmann ;
A Martinez ;
J A del Rio ;
E Soriano ;
P Vodrazka ;
R Kuner ;
H-J Groene ;
I Herr ;
P H Krammer ;
A Martin-Villalba .
Cell Death & Differentiation, 2006, 13 :31-40
[40]   Interaction of Fas(Apo-1/CD95) with proteins implicated in the ubiquitination pathway [J].
Becker, K ;
Schneider, P ;
Hofmann, K ;
Mattmann, C ;
Tschopp, J .
FEBS LETTERS, 1997, 412 (01) :102-106